Medicare Enrolled

Dr. Misha Denham, DO

Endocrinology · Coral Gables, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2695 S LE JEUNE RD, Coral Gables, FL 33134
3056728559
In practice since 2005 (20 years)
NPI: 1689659096 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Denham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Denham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Denham

Dr. Misha Denham is an endocrinology specialist in Coral Gables, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Denham performed 865 Medicare services across 536 unique beneficiaries.

Between the years covered by Open Payments, Dr. Denham received a total of $716,614 from 62 pharmaceutical and/or device companies across 1643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Denham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 47% volume in FL $716,614 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 9157 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
865
Medicare services
Top 47% in FL for endocrinology
536
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 375 $96 $195
Blood glucose (sugar) test performed by hand-held instrument 113 $3 $10
Drug injection, under skin or into muscle 89 $10 $40
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 89 $1 $5
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 78 $29 $90
Ultrasound scan of head and neck soft tissue 40 $88 $250
Office visit, established patient, complex (40-54 min) 36 $149 $245
Telephone medical discussion with physician, 21-30 minutes 33 $86 $185
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment 12 $120 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$716,614
Total received (2018-2024)
Avg $102,373/year across 7 years
Top 1% in FL for endocrinology
62
Companies
1,643
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$704,599 (98.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,191 (0.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,824 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$86,908
2023
$73,943
2022
$113,793
2021
$92,180
2020
$78,925
2019
$116,833
2018
$154,032

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$405,050
Novo Nordisk Inc
$225,875
Merck Sharp & Dohme Corporation
$40,850
Mannkind Corporation
$13,417
MannKind Corporation
$11,747
Janssen Pharmaceuticals, Inc
$11,564
Corcept Therapeutics
$2,549
Boehringer Ingelheim Pharmaceuticals, Inc.
$532
AstraZeneca Pharmaceuticals LP
$444
SANOFI-AVENTIS U.S. LLC
$431
Amgen Inc.
$362
Insulet Corporation
$335
Amarin Pharma Inc.
$315
AbbVie, Inc.
$306
Tandem Diabetes Care, Inc.
$216
Becton, Dickinson and Company
$173
Antares Pharma, Inc.
$170
IBSA Pharma Inc.
$170
Shire North American Group Inc
$129
Amneal Pharmaceuticals LLC
$109
AbbVie Inc.
$108
Currax Pharmaceuticals LLC
$105
Abbott Laboratories
$103
OPKO Pharmaceuticals, LLC
$97
Medtronic MiniMed, Inc.
$92
AIMMUNE THERAPEUTICS, INC.
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$72
CeQur Corporation
$70
EMD Serono, Inc.
$68
Xeris Pharmaceuticals, Inc.
$68
Azurity Pharmaceuticals, Inc.
$67
Medtronic, Inc.
$62
DEXCOM, INC.
$60
ABBVIE INC.
$60
Nestle HealthCare Nutrition Inc.
$52
Kyowa Kirin, Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$47
Zealand Pharma US, Inc.
$45
Verity Pharmaceuticals Inc.
$42
Dexcom, Inc.
$39
Gemini Laboratories, LLC
$37
Aytu BioScience, Inc
$32
LIFESCAN, INC.
$31
Radius Health, Inc.
$31
Allergan Inc.
$26
Nalpropion Pharmaceuticals LLC
$26
Embecta Corp.
$23
Senseonics, Incorporated
$23
Novartis Pharmaceuticals Corporation
$22
NESTLE HEALTHCARE NUTRITION INC.
$21
VIVUS LLC
$21
Ascendis Pharma Inc
$20
Alfasigma USA, Inc.
$20
Amryt Pharma Holdings Ltd
$20
Strongbridge US INC.
$19
Neurocrine Biosciences, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Acerus Pharmaceuticals Corporation
$17
Orexigen Therapeutics, Inc.
$17
Acella Pharmaceuticals, LLC
$15
Ultragenyx Pharmaceutical Inc.
$13
Clarus Therapeutics Inc.
$12
Top 3 companies account for 93.7% of total payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CONTRAVE · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUMET · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · MACRILEN · MINIMED 780G · MOUNJARO · MYCARELINK · Minimed Paradigm Revel · NATPARA · NOCDURNA · NP Thyroid · Natesto · ONETOUCH VERIO REFLECT · OTREXUP · Omnipod · Ozempic · PANCREAZE · Prolia · RYBELSUS · Rayaldee · Repatha · Rybelsus · SEROSTIM · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Saxenda · Serostim · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in FL.

Equivalent to $82,846 per 100 Medicare services performed
Looking for an endocrinology specialist in Coral Gables?
Compare endocrinologists in the Coral Gables area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
121
Per 100K population
4.5
County median income
$68,694
Nearest hospital
CORAL GABLES HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Denham is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Denham experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Denham performed 375 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Denham receive payments from pharmaceutical companies?
Yes. Dr. Denham received a total of $716,614 from 62 companies across 1,643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Denham's costs compare to other endocrinologists in Coral Gables?
Dr. Denham's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Denham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →